Potentiation of CCl4 hepatotoxicity in rats by a metabolite of 2-butanone: 2,3-butanediol
- PMID: 542953
- DOI: 10.1016/0300-483x(79)90003-9
Potentiation of CCl4 hepatotoxicity in rats by a metabolite of 2-butanone: 2,3-butanediol
Abstract
The role of ketaone metabolism in 2-butanone-induced potentiaion of carbon tetrachloride (CCl4) hepatotoxicity was studied in rats. The blood concentrations of 2-butanol, 3-hydroxy-2-butanone and 2,3-butanediol detected 4 h after dosing were 3.2 mg/100 ml, 2.4 mg/100 ml and 8.6 mg/100 ml, respectively. Eighteen hours after 2-butanone, the concentration of 2,3-butanediol rose to 25.6 mg/100 ml, while the concentrations of 2-butanol and 3-hydroxy-2-butanone declined to 0.6 mg/100 ml and 1.4 mg/100 ml, respectively. A 16-h pretreatment with either 2-butanone (2.1 ml/kg, p.o.) or 2,3-butanediol (2.12 ml/kg, p.o.) markedly enhanced the hepatotoxic response to CCl4 (0.1 ml/kg, i.p.), as measured by serum glutamic pyruvic transaminase activity and hepatic triglyceride content. In vivo, limited formation of 3-hydroxy-2-butanone occurred after this dose of 2,3-butanediol. These data suggest that the production of 3-hydroxy-2-butanone and 2,3-butanediol via 2-butanone metabolism may participate in the augmented necrogenic effect of CCl4 seen after pretreatment with 2-butanone.
Similar articles
-
The participation of 2-butanone in 2-butanol-induced potentiation of carbon tetrachloride hepatotoxicity.J Pharmacol Exp Ther. 1976 Feb;196(2):493-500. J Pharmacol Exp Ther. 1976. PMID: 1255493
-
Effect of 2-butanol and 2-butanone on rat hepatic ultrastructure and drug metabolizing enzyme activity.J Toxicol Environ Health. 1989;28(2):235-48. doi: 10.1080/15287398909531343. J Toxicol Environ Health. 1989. PMID: 2507790
-
Characterization of vitamin A potentiation of carbon tetrachloride-induced liver injury.Toxicol Appl Pharmacol. 1993 Apr;119(2):280-8. doi: 10.1006/taap.1993.1070. Toxicol Appl Pharmacol. 1993. PMID: 8480337
-
Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or strepto- zotocin-diabetic rats.J Pharmacol Exp Ther. 1975 Mar;192(3):592-604. J Pharmacol Exp Ther. 1975. PMID: 164533
-
Experimental evaluation of haloalkanes and liver injury.Fundam Appl Toxicol. 1988 May;10(4):563-70. doi: 10.1016/0272-0590(88)90183-2. Fundam Appl Toxicol. 1988. PMID: 3294072 Review.
Cited by
-
Kinetics of methyl ethyl ketone in man: absorption, distribution and elimination in inhalation exposure.Int Arch Occup Environ Health. 1988;60(3):195-200. doi: 10.1007/BF00378697. Int Arch Occup Environ Health. 1988. PMID: 3384485
-
Biological monitoring of occupational exposure to methyl ethyl ketone in Japanese workers.Arch Environ Contam Toxicol. 1995 Jul;29(1):135-9. doi: 10.1007/BF00213098. Arch Environ Contam Toxicol. 1995. PMID: 7794011
-
Pharmacokinetics of 2-butanol and its metabolites in the rat.J Pharmacokinet Biopharm. 1981 Oct;9(5):553-76. doi: 10.1007/BF01061026. J Pharmacokinet Biopharm. 1981. PMID: 7334459
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources